Cargando…
Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes
AIM: To identify risk factors predictive of or associated with gastrointestinal side effects (GISE) of liraglutide in patients with type 2 diabetes (T2DM). METHODS: T2DM patients treated with liraglutide for the first time were obtained and grouped into patients without GSEA and patients with GSEA....
Autores principales: | Wu, Hao, Lu, Zongshi, Chen, Runyao, Cai, Quanfang, Wang, Miaomiao, Zhang, Liting, Zhu, Zhiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922750/ https://www.ncbi.nlm.nih.gov/pubmed/36793278 http://dx.doi.org/10.3389/fendo.2023.1098032 |
Ejemplares similares
-
Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
por: Su, Yu, et al.
Publicado: (2023) -
Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes
por: Tan, Yijiong, et al.
Publicado: (2022) -
Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes
por: Hansen, Christian Stevns, et al.
Publicado: (2019) -
A Diabetic Patient Complicated With Pancreatic Cancer After Using Liraglutide: A Case Report
por: Wu, Shengjie, et al.
Publicado: (2021) -
The Discovery and Development of Liraglutide and Semaglutide
por: Knudsen, Lotte Bjerre, et al.
Publicado: (2019)